Gronberg bh et al. j clin oncol. 2009 27:3217
WebApr 20, 2009 · Purpose: Trastuzumab shows clinical activity in human epidermal growth factor receptor 2 (HER-2)-positive early and advanced breast cancer. In the German … WebMay 29, 2013 · Eight-two patients were enrolled on the trial between May 2008 and July 2011, comprising 56 (68.3%) males and 26 (31.7%) females with a median age of 58 …
Gronberg bh et al. j clin oncol. 2009 27:3217
Did you know?
WebDec 19, 2024 · Gronberg BH, Bremnes RM, Flotten O, et al. Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with … WebJun 1, 2024 · Abstract. Glioblastoma is the most common malignant primary brain tumor. Overall, the prognosis for patients with this disease is poor, with a median survival of <2 …
WebMay 11, 2009 · Purpose To compare pemetrexed/carboplatin with a standard regimen as first-line therapy in advanced non–small-cell lung cancer NSCLC. Patients and Methods … WebOct 1, 2009 · Patients and methods: This is a phase III, multicenter, randomized (1:1), double-blind, placebo-controlled study. Patients with non-Hodgkin's lymphoma requiring …
WebApr 12, 2024 · Journal of Clinical Oncology (JCO) is a high-impact, peer-reviewed medical journal that publishes significant clinical oncology research along with editorials, … WebAug 20, 2013 · The haematological toxicities were comparable to other studies (Helbekkmo et al, 2007; Gronberg et al, 2009; Takigawa et al, 2011), but the number of hospital admissions in relation to side ...
WebDec 10, 2009 · Purpose: To review and update the European LeukemiaNet (ELN) recommendations for the management of chronic myeloid leukemia with imatinib and second-generation tyrosine kinase inhibitors (TKIs), including monitoring, response definition, and first- and second-line therapy. Methods: These recommendations are …
WebOct 1, 2009 · Purpose: Somatostatin analogs are indicated for symptom control in patients with gastroenteropancreatic neuroendocrine tumors (NETs). The ability of somatostatin analogs to control the growth of well-differentiated metastatic NETs is a matter of debate. We performed a placebo-controlled, double-blind, phase IIIB study in patients with well … tesla model 3 how long to chargeWebAug 1, 2009 · Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy J Clin Oncol. 2009 Aug 1;27 (22):3677 … tring picturesWebDec 7, 2010 · Gronberg BH, Bremnes RM, Flotten O, Amundsen T, Brunsvig PF, Hjelde HH, et al. Phase III study by the Norwegian lung cancer study group: pemetrexed plus … tesla model 3 leather steering wheelWebMar 25, 2011 · Gronberg BH, Bremnes RM, Flotten O, et al. Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with … tesla model 3 lithium 12v batteryWebDec 1, 2009 · 10.1200/JCO.2009.23.2025 Abstract Purpose: To evaluate the risk of recurrence in women diagnosed with T1a and T1b, node-negative, human epidermal … tesla model 3 leasing prisWebJun 9, 2024 · Int J Radiat Oncol Biol Phys. 2009; 73: 1069-1076. Abstract; Full Text; ... Am J Clin Oncol. 2004; 27: 505-509. Crossref; PubMed; Scopus (29) Google Scholar; The analysis detected statistical heterogeneity (I 2 70%). ... Gronberg BH ; Ciuleanu T ; Flotten O ; et al. A placebo-controlled, randomized phase II study of maintenance enzastaurin ... tesla model 3 hitch bike rackWebJ Clin Oncol 2003; 21: ... Gronberg BH, Bremnes RM, Flotten O, et al. Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol 2009; 27: 3217 ... tring orthodontist